HEADER APOPTOSIS 11-JUL-06 2HM8 TITLE SOLUTION STRUCTURE OF THE C-TERMINAL MA-3 DOMAIN OF PDCD4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PDCD4 C-TERMINAL MA-3 DOMAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: MA-3 PROTEIN; COMPND 5 SYNONYM: PDCD4 PROTEIN; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: PDCD4, MA-3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PGEX6P2 KEYWDS ATYPICAL HEAT DOMAIN, APOPTOSIS EXPDTA SOLUTION NMR NUMMDL 49 AUTHOR L.C.WATERS,V.VEVERKA,M.BOHM,F.W.MUSKETT,P.T.CHOONG,K.H.KLEMPNAUER, AUTHOR 2 M.D.CARR REVDAT 3 09-MAR-22 2HM8 1 REMARK SEQADV REVDAT 2 23-DEC-08 2HM8 1 JRNL VERSN REVDAT 1 20-FEB-07 2HM8 0 JRNL AUTH L.C.WATERS,V.VEVERKA,M.BOHM,T.SCHMEDT,P.T.CHOONG, JRNL AUTH 2 F.W.MUSKETT,K.H.KLEMPNAUER,M.D.CARR JRNL TITL STRUCTURE OF THE C-TERMINAL MA-3 DOMAIN OF THE TUMOUR JRNL TITL 2 SUPPRESSOR PROTEIN PDCD4 AND CHARACTERIZATION OF ITS JRNL TITL 3 INTERACTION WITH EIF4A JRNL REF ONCOGENE V. 26 4941 2007 JRNL REFN ISSN 0950-9232 JRNL PMID 17310995 JRNL DOI 10.1038/SJ.ONC.1210305 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : VNMR 5.3, CYANA 2.1 REMARK 3 AUTHORS : VARIAN (VNMR), GUENTERT (CYANA) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2HM8 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUL-06. REMARK 100 THE DEPOSITION ID IS D_1000038508. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 150MM REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.7MM U-15N, 13C PDCD4 MA-3C; REMARK 210 100MM NACL, 25MM NAH2PO4, 0.5MM REMARK 210 DTT, 10UM EDTA, PH6.5; 0.6MM U- REMARK 210 15N PDCD4 MA-3C; 100MM NACL, REMARK 210 25MM NAH2PO4, 0.5MM DTT, 10UM REMARK 210 EDTA, PH6.5; 1MM U-13C REMARK 210 (UNLABELLED AROMATICS) PDCD4 MA- REMARK 210 3C; 100MM NACL, 25MM NAH2PO4, REMARK 210 0.5MM DTT, 10UM EDTA, PH6.5; 1MM REMARK 210 UNLABELLED 13C PDCD4 MA-3C; REMARK 210 100MM NACL, 25MM NAH2PO4, 0.5MM REMARK 210 DTT, 10UM EDTA, PH6.5 REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; 2D TOCSY; 3D_13C REMARK 210 -SEPARATED_NOESY; 3D_15N- REMARK 210 SEPARATED_NOESY; 3D HCCH-TOCSY; REMARK 210 3D_15N TOCSY; 3D HNCACB; 3D REMARK 210 CBCA(CO)NH REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ; 800 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; DRX; INOVA REMARK 210 SPECTROMETER MANUFACTURER : BRUKER; VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN 1.2, NMRPIPE REMARK 210 97.027.12.56, SPARKY 3, CYANA 2.1 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 49 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 33 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LEU A 316 -174.22 55.00 REMARK 500 1 GLU A 355 55.87 -115.33 REMARK 500 1 SER A 374 -176.88 -59.60 REMARK 500 1 ILE A 412 62.03 -119.94 REMARK 500 1 ASN A 416 -63.17 -97.24 REMARK 500 1 LEU A 417 -75.04 -52.65 REMARK 500 1 VAL A 419 76.27 63.88 REMARK 500 1 HIS A 421 -35.01 -179.04 REMARK 500 2 SER A 318 34.08 -156.78 REMARK 500 2 PRO A 323 86.45 -69.74 REMARK 500 2 GLU A 355 54.46 -111.05 REMARK 500 2 GLU A 377 -33.30 179.40 REMARK 500 2 GLU A 411 -76.19 -92.93 REMARK 500 2 ILE A 412 58.77 35.31 REMARK 500 2 VAL A 419 76.01 63.77 REMARK 500 3 GLU A 355 53.02 -105.82 REMARK 500 3 HIS A 358 31.84 -96.58 REMARK 500 3 PHE A 359 87.40 -179.17 REMARK 500 3 HIS A 360 13.35 -142.15 REMARK 500 3 SER A 374 -170.02 -60.30 REMARK 500 3 THR A 375 -39.62 -131.76 REMARK 500 3 THR A 397 155.95 64.48 REMARK 500 3 ASN A 416 73.74 -113.91 REMARK 500 3 ASP A 418 91.70 54.65 REMARK 500 3 VAL A 419 74.70 64.43 REMARK 500 4 ASN A 325 56.70 -94.32 REMARK 500 4 GLU A 355 52.47 -119.31 REMARK 500 4 PHE A 359 91.41 -179.54 REMARK 500 4 SER A 374 -169.30 -62.90 REMARK 500 4 THR A 375 -40.41 -135.28 REMARK 500 4 LEU A 417 -75.18 -65.61 REMARK 500 4 VAL A 419 78.39 -116.42 REMARK 500 4 PRO A 420 79.08 -69.79 REMARK 500 4 HIS A 421 -34.64 -179.34 REMARK 500 5 SER A 318 -49.99 -142.78 REMARK 500 5 ASN A 325 39.38 -99.31 REMARK 500 5 GLU A 355 63.91 -117.29 REMARK 500 5 HIS A 360 -41.49 -144.50 REMARK 500 5 SER A 374 -178.74 -57.21 REMARK 500 5 GLU A 411 -75.20 -84.43 REMARK 500 5 ILE A 412 67.38 35.28 REMARK 500 5 PRO A 413 -86.72 -69.88 REMARK 500 5 LEU A 417 -74.28 -51.92 REMARK 500 5 VAL A 419 73.84 53.60 REMARK 500 5 PRO A 420 95.29 -69.75 REMARK 500 5 HIS A 421 -34.90 -179.35 REMARK 500 6 PRO A 323 82.69 -69.80 REMARK 500 6 GLU A 355 68.30 -116.01 REMARK 500 6 VAL A 356 77.26 -117.70 REMARK 500 6 PHE A 359 89.94 -179.69 REMARK 500 REMARK 500 THIS ENTRY HAS 496 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2HM8 A 319 449 UNP Q61823 Q61823_MOUSE 319 449 SEQADV 2HM8 GLY A 314 UNP Q61823 INSERTION SEQADV 2HM8 PRO A 315 UNP Q61823 INSERTION SEQADV 2HM8 LEU A 316 UNP Q61823 INSERTION SEQADV 2HM8 GLY A 317 UNP Q61823 INSERTION SEQADV 2HM8 SER A 318 UNP Q61823 INSERTION SEQRES 1 A 136 GLY PRO LEU GLY SER GLY GLY GLN GLN PRO VAL ASN HIS SEQRES 2 A 136 LEU VAL LYS GLU ILE ASP MET LEU LEU LYS GLU TYR LEU SEQRES 3 A 136 LEU SER GLY ASP ILE SER GLU ALA GLU HIS CYS LEU LYS SEQRES 4 A 136 GLU LEU GLU VAL PRO HIS PHE HIS HIS GLU LEU VAL TYR SEQRES 5 A 136 GLU ALA ILE VAL MET VAL LEU GLU SER THR GLY GLU SER SEQRES 6 A 136 ALA PHE LYS MET ILE LEU ASP LEU LEU LYS SER LEU TRP SEQRES 7 A 136 LYS SER SER THR ILE THR ILE ASP GLN MET LYS ARG GLY SEQRES 8 A 136 TYR GLU ARG ILE TYR ASN GLU ILE PRO ASP ILE ASN LEU SEQRES 9 A 136 ASP VAL PRO HIS SER TYR SER VAL LEU GLU ARG PHE VAL SEQRES 10 A 136 GLU GLU CYS PHE GLN ALA GLY ILE ILE SER LYS GLN LEU SEQRES 11 A 136 ARG ASP LEU CYS PRO SER HELIX 1 1 ASN A 325 GLY A 342 1 18 HELIX 2 2 ASP A 343 LEU A 354 1 12 HELIX 3 3 VAL A 356 SER A 374 1 19 HELIX 4 4 GLY A 376 SER A 393 1 18 HELIX 5 5 THR A 397 TYR A 409 1 13 HELIX 6 6 HIS A 421 GLY A 437 1 17 HELIX 7 7 SER A 440 CYS A 447 1 8 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1